Description

AdvaCare is a CE, ISO and USFDA Listed manufacturer of COVID-19 (Coronavirus) IgG/IgM Test Kit.

AccuQuik COVID-19 IgG/IgM Rapit Test kit is a lateral flow immunoassay for the simultaneous detection and differentiation of IgG anti-COVID-19 virus and IgM anti-COVID-19 virus in human whole blood, serum, or plasma. It is intended to be used by the professionals as a screening test and as an aid in the diagnosis of infection with COVID-19 viruses (SARS-CoV-2).

Coronaviruses are enveloped RNA viruses that are distributed broadly among humans, other mammals, and birds and that cause respiratory, enteric, hepatic, and neurological diseases. Six coronavirus species are known to cause human diseases. Four viruses – 229E, OC43, NL63, and HKU1 – are prevalent and typically cause common cold symptoms in immunocompetent individuals. The two other strains — severe acute respiratory syndrome coronavirus (SARS-CoV) and Middle East respiratory syndrome coronavirus (MERS-CoV) — are zoonotic in origin and have been linked to sometimes fatal illness. Given the high prevalence and wide distribution of coronaviruses, the large genetic diversity and frequent recombination of their genomes, and increasing human–animal interface activities, novel coronaviruses are likely to emerge periodically in humans owing to frequent cross-species infections and occasional spillover events.

AccuQuik COVID-19 Rapid Test Kit detects IgG and IgM anti-COVID-19 virus in one test within 10 minutes. The test is user friendly, without cumbersome laboratory equipment, and requires minimal staff trainings.

COVID-19 IgG/IgM Rapid Test Device (Whole Blood/Serum/Plasma) is a qualitative membrane-based immunoassay for the detection of COVID-19 antibodies in whole blood, serum, or plasma. This test consists of two components, an IgG component and an IgM component. In the test region, anti-human IgM and IgG is coated. During testing, the specimen reacts with COVID-19 antigen-coated particles in the test strip. The mixture then migrates upward on the membrane chromatographically by capillary action and reacts with the anti-human IgM or IgG in test line region. If the specimen contains IgM or IgG antibodies to COVID-19, a colored line will appear in test line region.

Therefore, if the specimen contains COVID-19 IgM antibodies, a colored line will appear in test line region M. If the specimen contains COVID-19 IgG antibodies, a colored line will appear in test line region G. If the specimen does not contain COVID-19 antibodies, no colored line will appear in either of the test line regions, indicating a negative result. To serve as a procedural control, a colored line will always appeared in the control line region, indicating that the proper volume of specimen has been added and membrane wicking has occurred.

Conversely to Polymerase Chain Reaction test kits (PCR) – in both of their typologies used (such as nasopharyngeal or oropharyngeal swabs, sputum, lower respiratory tract aspirates, bronchoalveolar lavage, and nasopharyngeal wash/aspirate or nasal aspirate) – used, nowadays, to confirm patients with COVID-19 infection which takes up to 3 hours for results, AccuQuik™ COVID-19 IgG/IgM Rapid Test Kit can detect COVID-19 with an accuracy of 97.9% in ten minutes!